ArticleInternational urology and nephrology2026
Prostate MR image segmentation using a multi-stage network approach.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of long non-coding RNA HCG11 in human cancers: From molecular mechanisms to clinical applications (Review).Oncology letters · 2026Review
- RepSAU-Net: Semantic Segmentation of Barcodes in Complex Backgrounds via Fused Self-Attention and Reparameterization Methods.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer (PCa) remains one of the most prevalent cancers among men, with over 1.4 million new cases and 375,304 deaths reported globally in 2020. Current diagnostic approaches, such as prostate-specific antigen (PSA) testing and trans-rectal ultrasound (TRUS)-guided biopsies, are often Limited by low specificity and accuracy. This study addresses these Limitations by leveraging deep learning-based image segmentation techniques on a dataset comprising 61,119 T2-weighted MR images from 1151 patients to enhance PCa detection and characterisation. A multi-stage segmentation approach, including one-stage, sequential two-stage, and end-to-end two-stage methods, was evaluated using various deep learning architectures. The MultiResUNet model, integrated into a multi-stage segmentation framework, demonstrated significant improvements in delineating prostate boundaries. The study utilised a dataset of over 61,000 T2-weighted magnetic resonance (MR) images from more than 1100 patients, employing three distinct segmentation strategies: one-stage, sequential two-stage, and end-to-end two-stage methods. The end-to-end approach, leveraging shared feature representations, consistently outperformed other methods, underscoring its effectiveness in enhancing diagnostic accuracy. These findings highlight the potential of advanced deep learning architectures in streamlining prostate cancer detection and treatment planning. Future work will focus on further optimisation of the models and assessing their generalisability to diverse medical imaging contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.